- Home
- RMBL vs TRVI Comparison
RMBL vs TRVI Comparison
Compare RMBL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBL
- TRVI
- Stock Information
- Founded
- RMBL 2013
- TRVI 2011
- Country
- RMBL United States
- TRVI United States
- Employees
- RMBL N/A
- TRVI N/A
- Industry
- RMBL EDP Services
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- RMBL Technology
- TRVI Health Care
- Exchange
- RMBL Nasdaq
- TRVI Nasdaq
- Market Cap
- RMBL 81.4M
- TRVI 725.7M
- IPO Year
- RMBL N/A
- TRVI 2019
- Fundamental
- Price
- RMBL $2.45
- TRVI $5.70
- Analyst Decision
- RMBL Hold
- TRVI Strong Buy
- Analyst Count
- RMBL 4
- TRVI 9
- Target Price
- RMBL $4.50
- TRVI $19.94
- AVG Volume (30 Days)
- RMBL 233.8K
- TRVI 2.2M
- Earning Date
- RMBL 08-06-2025
- TRVI 08-07-2025
- Dividend Yield
- RMBL N/A
- TRVI N/A
- EPS Growth
- RMBL N/A
- TRVI N/A
- EPS
- RMBL N/A
- TRVI N/A
- Revenue
- RMBL $1,146,100,000.00
- TRVI N/A
- Revenue This Year
- RMBL N/A
- TRVI N/A
- Revenue Next Year
- RMBL $8.09
- TRVI N/A
- P/E Ratio
- RMBL N/A
- TRVI N/A
- Revenue Growth
- RMBL N/A
- TRVI N/A
- 52 Week Low
- RMBL $1.46
- TRVI $2.36
- 52 Week High
- RMBL $7.06
- TRVI $7.48
- Technical
- Relative Strength Index (RSI)
- RMBL 55.21
- TRVI 41.92
- Support Level
- RMBL $2.12
- TRVI $5.41
- Resistance Level
- RMBL $2.42
- TRVI $5.96
- Average True Range (ATR)
- RMBL 0.20
- TRVI 0.29
- MACD
- RMBL 0.04
- TRVI -0.06
- Stochastic Oscillator
- RMBL 58.06
- TRVI 24.79
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.